Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yaan Song, Ming Yuan & Guoyun Wang. (2023) Update value and clinical application of MUC16 (cancer antigen 125). Expert Opinion on Therapeutic Targets 27:8, pages 745-756.
Read now
Read now
Articles from other publishers (19)
Nan Li, Lingli Cao, Kexin Zhao & Yonghui Feng. (2023) Development and validation of a nomogram to predict Chinese breast cancer risk based on clinical serum biomarkers. Biomarkers in Medicine 17:5, pages 273-286.
Crossref
Crossref
Maryam Koopaie, Mahsa Jomehpoor, Soheila Manifar, Reza Mousavi & Sajad Kolahdooz. (2022) Evaluation of Salivary KCNJ3 mRNA Levels in Breast Cancer: A Case–control Study and in silico Analysis. The Open Dentistry Journal 16:1.
Crossref
Crossref
Wenxiao Hu, Yue Wang, Mengyao Qian, Luhui Wang & Yafei Dong. (2020) A Label-free “Lock-key” Fluorescence Aptasensing Based on Triplex-helix DNA and G-quadruplex for CA15-3 Detection. Analytical Sciences 37:6, pages 905-909.
Crossref
Crossref
Huihui Chen, Shijie Wu, Jun Hu, Kun Zhang, Kaimin Hu, Yuexin Lu, Jiapan He, Tao Pan & Yiding Chen. (2021) Prognostic Models for Nonmetastatic Triple-Negative Breast Cancer Based on the Pretreatment Serum Tumor Markers with Machine Learning. Journal of Oncology 2021, pages 1-13.
Crossref
Crossref
Junxian Li, Luyang Liu, Ziwei Feng, Xin Wang, Yubei Huang, Hongji Dai, Liwen Zhang, Fangfang Song, Dezheng Wang, Pengyu Zhang, Baoshan Ma, Haixin Li, Hong Zheng, Fengju Song & Kexin Chen. (2020) Tumor markers CA15-3, CA125, CEA and breast cancer survival by molecular subtype: a cohort study. Breast Cancer 27:4, pages 621-630.
Crossref
Crossref
Juan Li, Hang Li, Xiaoting Lv, Zitai Yang, Min Gao, Yanhong Bi, Ziwei Zhang, Shengli Wang, Zhigang Cui, Baosen Zhou & Zhihua Yin. (2019) Diagnostic performance of circular RNAs in human cancers: A systematic review and meta‐analysis. Molecular Genetics & Genomic Medicine 7:7.
Crossref
Crossref
Somayeh Hamd-Ghadareh, Abdollah Salimi, Sara Parsa & Fardin Fathi. (2018) Simultaneous biosensing of CA125 and CA15-3 tumor markers and imaging of OVCAR-3 and MCF-7 cells lines via bi-color FRET phenomenon using dual blue-green luminescent carbon dots with single excitation wavelength. International Journal of Biological Macromolecules 118, pages 617-628.
Crossref
Crossref
Wen-Zhao Chen, Jun-Feng Shen, Yang Zhou, Xuan-Yin Chen, Jia-Ming Liu & Zhi-Li Liu. (2017) Clinical characteristics and risk factors for developing bone metastases in patients with breast cancer. Scientific Reports 7:1.
Crossref
Crossref
Cheng Fang, Yue Cao, Xiaoping Liu, Xian-Tao Zeng & Yirong Li. (2017) Serum CA125 is a predictive marker for breast cancer outcomes and correlates with molecular subtypes. Oncotarget 8:38, pages 63963-63970.
Crossref
Crossref
Dorit Di Gioia, Irene Blankenburg, Dorothea Nagel, Volker Heinemann & Petra Stieber. (2016) Tumor markers in the early detection of tumor recurrence in breast cancer patients: CA 125, CYFRA 21-1, HER2 shed antigen, LDH and CRP in combination with CEA and CA 15-3. Clinica Chimica Acta 461, pages 1-7.
Crossref
Crossref
June-Hyung HaMin-Ki SeongEun-Kyu KimJin Kyung LeeHyesil SeolJu Young LeeJangmoo ByeonYeun-Ju SohnJae Soo KohIn-Chul ParkWoo Chul NohHyun-Ah Kim. (2014) Serial Serum HER2 Measurements for the Detection of Breast Cancer Recurrence in HER2-Positive Patients. Journal of Breast Cancer 17:1, pages 33.
Crossref
Crossref
Franca Maria Tuccillo, Annamaria de Laurentiis, Camillo Palmieri, Giuseppe Fiume, Patrizia Bonelli, Antonella Borrelli, Pierfrancesco Tassone, Iris Scala, Franco Maria Buonaguro, Ileana Quinto & Giuseppe Scala. (2014) Aberrant Glycosylation as Biomarker for Cancer: Focus on CD43. BioMed Research International 2014, pages 1-13.
Crossref
Crossref
Alireza EsteghamatiSeyedomid SeyedahmadinejadAli ZandiehAbdoulreza EsteghamatiMohammad Hadi GharedaghiMohammad Salehi SadaghianiAfshin SaadipoorManouchehr Nakhjavani. (2013) The Inverse Relation of CA-125 to Diabetes, Metabolic Syndrome, and Associated Clinical Variables. Metabolic Syndrome and Related Disorders 11:4, pages 256-261.
Crossref
Crossref
Xu Yu, He-Shun Xia, Zuo-Dong Sun, Yi Lin, Kun Wang, Jing Yu, Hao Tang, Dai-Wen Pang & Zhi-Ling Zhang. (2013) On-chip dual detection of cancer biomarkers directly in serum based on self-assembled magnetic bead patterns and quantum dots. Biosensors and Bioelectronics 41, pages 129-136.
Crossref
Crossref
R. Yerushalmi, S. Tyldesley, H. Kennecke, C. Speers, R. Woods, B. Knight & K.A. Gelmon. (2012) Tumor markers in metastatic breast cancer subtypes: frequency of elevation and correlation with outcome. Annals of Oncology 23:2, pages 338-345.
Crossref
Crossref
Angel González-Sistal, José Ignacio Arias & Álvaro Ruibal. (2018) CA 15–3 Serum Levels in Patients with Ductal Breast Carcinoma: Relationship with Clinicopathological Parameters and Tumor Markers. The International Journal of Biological Markers 27:1, pages 47-52.
Crossref
Crossref
Simon A Fry, Babak Afrough, Hannah J Lomax-Browne, John F Timms, Louiza S Velentzis & Anthony JC Leathem. (2011) Lectin microarray profiling of metastatic breast cancers. Glycobiology 21:8, pages 1060-1070.
Crossref
Crossref
Celso A Reis, Hugo Osorio, Luisa Silva, Catarina Gomes & Leonor David. (2010) Alterations in glycosylation as biomarkers for cancer detection. Journal of Clinical Pathology 63:4, pages 322-329.
Crossref
Crossref
Yunchao Gao, Hankui Lu, Zhibin Yuan & Ruisen Zhu. (2009) Tumor Markers in Thyroid Carcinoma With Pulmonary Metastases After Thyroidectomy. Laboratory Medicine 40:1, pages 30-34.
Crossref
Crossref